Detailed information for compound 1105545

Basic information

Technical information
  • TDR Targets ID: 1105545
  • Name: N-[(1S,3aS,3bR,5aR,9aR,9bS,11aS)-6,9a,11a-tri methyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-do decahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-cy clopropylformamide
  • MW: 372.544 | Formula: C23H36N2O2
  • H donors: 0 H acceptors: 2 LogP: 4.26 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=CN([C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC[C@@H]2[C@]1(C)CCC(=O)N2C)C1CC1
  • InChi: 1S/C23H36N2O2/c1-22-13-11-21(27)24(3)19(22)8-6-16-17-7-9-20(25(14-26)15-4-5-15)23(17,2)12-10-18(16)22/h14-20H,4-13H2,1-3H3/t16-,17-,18-,19+,20-,22+,23-/m0/s1
  • InChiKey: SNGXJCVQBMSSNF-MAMZKFLISA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • N-[(1S,3aS,3bR,5aR,9aR,9bS,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-cyclopropyl-formamide
  • N-[(1S,3aS,3bR,5aR,9aR,9bS,11aS)-7-keto-6,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-cyclopropyl-formamide
  • N-[(1S,3aS,3bR,5aR,9aR,9bS,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-cyclopropyl-methanamide

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Trichomonas vaginalis 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0377 0 0.5
Echinococcus multilocularis tyrosine protein phosphatase non receptor type 0.2844 1 1
Echinococcus granulosus tyrosine protein phosphatase non receptor type 0.2844 1 1
Trypanosoma cruzi 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0377 0 0.5
Echinococcus multilocularis receptor type tyrosine protein phosphatase protein tyrosine phosphatase receptor type 0.1083 0.2861 0.1231
Echinococcus granulosus receptor type tyrosine protein phosphatase 0.1083 0.2861 0.1231
Trichomonas vaginalis 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0377 0 0.5
Leishmania major 3-oxo-5-alpha-steroid 4-dehydrogenase-like protein 0.0377 0 0.5
Trypanosoma brucei 3-oxo-5-alpha-steroid 4-dehydrogenase-like, putative 0.0377 0 0.5
Trichomonas vaginalis 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0377 0 0.5
Mycobacterium ulcerans hypothetical protein 0.0377 0 0.5
Entamoeba histolytica steroid 5-alpha reductase, putative 0.0377 0 0.5
Loa Loa (eye worm) pre-B cell enhancing factor 0.0836 0.1859 0.1859
Toxoplasma gondii 3-oxo-5-alpha-steroid 4-dehydrogenase 0.0377 0 0.5
Trypanosoma cruzi 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0377 0 0.5
Brugia malayi Pre-B cell enhancing factor precursor 0.0836 0.1859 0.1859
Loa Loa (eye worm) protein-tyrosine phosphatase 0.2844 1 1
Echinococcus granulosus receptor type tyrosine protein phosphatase 0.1083 0.2861 0.1231
Schistosoma mansoni protein tyrosine phosphatase non-receptor type nt1 0.2844 1 1

Activities

Activity type Activity value Assay description Source Reference
Inhibition (binding) = 17.6 % Inhibition of human 17beta-HSD7 expressed in HEK293 cells assessed as inhibition of reduction of [14C]estrone into [14C]estradiol at 0.3 uM after 7 hrs ChEMBL. 19772289
Inhibition (binding) = 41.2 % Inhibition of human 17beta-HSD7 expressed in HEK293 cells assessed as inhibition of reduction of [14C]estrone into [14C]estradiol at 3 uM after 7 hrs ChEMBL. 19772289

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.